The application of lung immune prognostic index in predicting the prognosis of 302 STS patients
This study explored the efficacy of the LIPI in predicting the prognosis of 302 patients with STS, classifying them into three categories to evaluate the prognosis. It also reconstructed a LIPI-based nomogram to assist clinicians in predicting the three- and five-year OS of patients with STS, potentially enabling timely intervention and customized management.
Authors
- Longqing Li
- Minxun Lu
- Chang Zou (ORCID: https://orcid.org/0000-0002-2003-7834)
- Yong Zhou (ORCID: https://orcid.org/0000-0002-1078-6137)
- Yong Jiang (ORCID: https://orcid.org/0000-0001-6047-3342)
- Zhuangzhuang Li (ORCID: https://orcid.org/0000-0002-5582-2357)
- Xuanhong He (ORCID: https://orcid.org/0000-0003-1787-9704)
- Taojun Gong (ORCID: https://orcid.org/0000-0002-3374-954X)
- Li Min (ORCID: https://orcid.org/0000-0001-8704-8805)
- Yitian Wang (ORCID: https://orcid.org/0000-0002-9920-1931)
- Yi Luo (ORCID: https://orcid.org/0000-0003-4470-220X)
- Chongqi Tu (ORCID: https://orcid.org/0000-0002-1781-4073)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-09-09
- DOI
- https://doi.org/10.3389/fonc.2024.1460600
- Citations
- 1
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- Sichuan University
- West China Hospital, Sichuan University